Please login to the form below

Not currently logged in
Email:
Password:

pharma reputation

This page shows the latest pharma reputation news and features for those working in and with pharma, biotech and healthcare.

FDA chief Scott Gottlieb to step down

FDA chief Scott Gottlieb to step down

The news has nevertheless come as a surprise to the pharma and biotech sectors, where Gottlieb has been viewed as a great success since being appointed by President Trump in 2017. ... Gottlieb’s reputation has remained high in the pharma and biotech

Latest news

  • The shifting healthcare landscape The shifting healthcare landscape

    Pharma must fully embrace new technology and analytics, and adopt a more patient-centric model. ... reputation. The role of comms in pharma’s future. Sharpen social media approach and attract new partners.

  • Asian patient groups give pharma above average marks for reputation Asian patient groups give pharma above average marks for reputation

    PatientView’s 2016 Corporate Reputation of Pharma Companies survey covers the efforts of 16 global pharma companies including Pfizer- which was ranked the most familiar to the Asian patient groups. ... Respondents also ranked AbbVie as overall first

  • Pharma's reputation on the wane, say patient groups Pharma's reputation on the wane, say patient groups

    The pharma industry's reputation with patient groups has taken a turn for the worse, with the latest PatientView survey showing a decline across a majority of metrics. ... Overall, only 23% of patient groups thought that pharma's corporate reputation had

  • GSK draws line under Chinese scandal with $20m SEC settlement GSK draws line under Chinese scandal with $20m SEC settlement

    GSK's reputation was severely dented in the wake of the scandal, which centred on claims that the company paid almost $490m in kickbacks to drug prescribers using a network of

  • A new era of collaboration A new era of collaboration

    health, and for pharma to be prepared to adjust its ways of working accordingly. ... public health, benefit governments and improve the reputation of pharma.

More from news
Approximately 23 fully matching, plus 46 partially matching documents found.

Latest Intelligence

  • Diversity and inclusion in the pharma industry Diversity and inclusion in the pharma industry

    Not exactly equality. Yes, this isn’t the same as equal pay but what it highlights is that the pharma industry is not an equal ‘paying ground’ for female employees. ... As a leading business sector that touches the lives of everyone and  often

  • Righting pharma’s reputational wrongs Righting pharma’s reputational wrongs

    And, crucially, to move the story of our industry beyond ‘easy-target pharma’. ... It is imperative that the reputation of our industry is of the same high standard as the science that underpins it.

  • Tracking comms trends: 2 + 2 = 7: bad maths, or good sense? Tracking comms trends: 2 + 2 = 7: bad maths, or good sense?

    From multi-disciplinary teamwork to pharma’s reputation, value and access to global briefs, our contributors tackle some of the key topics in communications today. ... For both of these trends we are seeing pharma look outside its own walls – fresh,

  • Tracking comms trends: Europe in the global vanguard on value Tracking comms trends: Europe in the global vanguard on value

    From multi-disciplinary teamwork to pharma’s reputation, value and access to global briefs, our contributors tackle some of the key topics in communications today. ... I n recent years European healthcare payers have harassed and challenged the pharma

  • Tracking comms trends: Applying a global brief to a local market Tracking comms trends: Applying a global brief to a local market

    From multi-disciplinary teamwork to pharma’s reputation, value and access to global briefs, our contributors tackle some of the key topics in communications today.

More from intelligence
Approximately 0 fully matching, plus 10 partially matching documents found.

Latest appointments

  • Building trust in our industry Building trust in our industry

    Indeed, pharma is the only sub-sector within healthcare to buck an upward trend. ... Other findings of the Trust Barometer do provide some consolation though, in suggesting how pharma might go about repairing its reputation.

More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 4 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Research Partnership

We are the largest independent healthcare market research and consulting agencies in the world. Trusted partner to the global pharmaceutical...

Latest intelligence

The Exhibition Hall: Past, Present and Future
As I sit here at another pharma conference, I start to reflect on how they have changed over the years....
Success breeds success
This week we received the exciting news that we have been shortlisted for the Times Business Awards 2019, Tunbridge Wells in the 'Best Business 1-25 Employees' category....
Turning learning into action: The challenge of behaviour change
...

Infographics